Movano Inc. Form 10-Q Summary
Entity note: The request metadata names Corvex, Inc., but the supplied filing is for Movano Inc. (Nasdaq: MOVE). This summary reflects the filing text.
Business context and reporting period
Quarterly report for the three and six months ended June 30, 2022. Movano is a development-stage medical technology company developing a platform and the Movano Ring, a wearable intended to track health metrics and provide personalized feedback. The company had not completed product development and had recorded no revenue as of June 30, 2022.
Financial results and liquidity
| Metric | Three months ended June 30, 2022 | Six months ended June 30, 2022 | Comparable 2021 period |
|---|---|---|---|
| Revenue | None | None | None |
| Research and development expense | $4.112 million | $8.703 million | $3.183 million; $5.125 million |
| General and administrative expense | $2.734 million | $5.081 million | $1.863 million; $3.187 million |
| Total operating expenses / operating loss | $6.846 million / $(6.846) million | $13.784 million / $(13.784) million | $5.046 million / $(5.046) million; $8.312 million / $(8.312) million |
| Net loss | $(6.868) million | $(13.800) million | $(4.687) million; $(10.295) million |
| Basic and diluted loss per share | $(0.21) | $(0.42) | $(0.15); $(0.64) |
All figures are in U.S. dollars. Margins are not meaningful because the company had no revenue. Six-month operating cash use was $12.153 million, versus $7.772 million in 2021. Investing activities provided $11.548 million, mainly from investment maturities; financing provided $19,000. Cash and cash equivalents were $17.089 million and short-term investments were $4.214 million at quarter-end, together $21.303 million, down from $33.596 million at December 31, 2021.
Total assets were $24.392 million, total liabilities $3.895 million, and stockholders’ equity $20.497 million. The filing reports no outstanding convertible notes at June 30, 2022; those notes converted to common stock in the 2021 IPO. Recorded liabilities include operating lease obligations. No interest-bearing debt balance is reported in the supplied financial statements.
Changes versus the prior comparable periods
- Second-quarter operating expenses rose 36% year over year; six-month operating expenses rose 66%, reflecting company growth and increased activity.
- Second-quarter net loss increased to $6.868 million from $4.687 million. Six-month net loss increased to $13.800 million from $10.295 million.
- Six-month R&D expense increased 70% and G&A expense increased 59% year over year.
- Cash used in operations increased to $12.153 million from $7.772 million for the first half. The prior-year period included $45.019 million of net IPO proceeds, while 2022 financing cash flow was limited to $19,000.
- Lower 2022 six-month net loss attributable to common stockholders relative to the reported 2021 amount was partly due to the absence of 2021 preferred-stock accretion and one-time financing-related expenses and fair-value changes.
Outlook, risks, contingencies and unusual items
- Management expects significant expenses and increasing operating losses for at least the next several years while advancing product development, regulatory work, manufacturing and commercialization planning. No specific revenue, launch, or earnings guidance is provided.
- The company states that its cash and investments are not expected to fund completion of development and commercialization. It expects to need additional financing; management disclosed substantial doubt about the company’s ability to continue as a going concern within one year after issuance of the financial statements.
- On August 15, 2022, after quarter-end, Movano entered an at-the-market agreement allowing it to sell up to $50 million of common stock. It is not obligated to sell shares; any sales could dilute existing shareholders. The company said proceeds would be used for general corporate purposes.
- Principal risks include product and technology development, regulatory approvals, commercialization, competition, reliance on third parties, intellectual property protection, access to capital, and the effects of COVID-19 and economic conditions. The company reported no material change to the risk factors in its 2021 Form 10-K.
- Disclosure controls and procedures were deemed ineffective as of June 30, 2022 due to a material weakness involving financial close and reporting controls, including account reviews and analyses and certain IT general controls. Management said remediation efforts were underway.
- The company reported no litigation believed likely to have a material adverse effect and no material off-balance-sheet arrangements. Adoption of lease accounting in 2022 resulted in recognition of lease right-of-use assets and liabilities; management said adoption did not materially affect results or cash flows.
Most important facts for investors to verify
- Confirm that the intended issuer is Movano Inc., not Corvex, Inc.
- Monitor cash burn, financing needs, and any actual sales under the $50 million ATM program, including resulting dilution.
- Track product-development milestones, regulatory requirements, and evidence supporting the expected market and commercialization plans.
- Assess progress in remediating the disclosed material weakness and whether disclosure controls improve in subsequent filings.
- Review subsequent filings for changes in liquidity, going-concern disclosures, lease obligations, and stock-based compensation or other potential dilution.